Annual Total Assets
$6.84 B
+$466.53 M+7.32%
31 December 2023
Summary:
BioMarin Pharmaceutical annual total assets is currently $6.84 billion, with the most recent change of +$466.53 million (+7.32%) on 31 December 2023. During the last 3 years, it has risen by +$993.58 million (+16.99%). BMRN annual total assets is now at all-time high.BMRN Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$6.85 B
-$215.93 M-3.06%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly total assets is currently $6.85 billion, with the most recent change of -$215.93 million (-3.06%) on 30 September 2024. Over the past year, it has increased by +$93.03 million (+1.38%). BMRN quarterly total assets is now -3.06% below its all-time high of $7.07 billion, reached on 30 June 2024.BMRN Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.3% | +1.4% |
| 3 y3 years | +17.0% | +14.6% |
| 5 y5 years | +54.5% | +50.3% |
BMRN Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +17.0% | -3.1% | +14.6% |
| 5 y | 5 years | at high | +54.5% | -3.1% | +50.3% |
| alltime | all time | at high | >+9999.0% | -3.1% | >+9999.0% |
BioMarin Pharmaceutical Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.85 B(-3.1%) |
| June 2024 | - | $7.07 B(+2.8%) |
| Mar 2024 | - | $6.87 B(+0.5%) |
| Dec 2023 | $6.84 B(+7.3%) | $6.84 B(+1.2%) |
| Sept 2023 | - | $6.76 B(+3.0%) |
| June 2023 | - | $6.56 B(+2.0%) |
| Mar 2023 | - | $6.43 B(+0.9%) |
| Dec 2022 | $6.38 B(+6.2%) | $6.38 B(+1.8%) |
| Sept 2022 | - | $6.26 B(+1.9%) |
| June 2022 | - | $6.15 B(+1.4%) |
| Mar 2022 | - | $6.06 B(+1.0%) |
| Dec 2021 | $6.00 B(+2.7%) | $6.00 B(+0.5%) |
| Sept 2021 | - | $5.98 B(+1.3%) |
| June 2021 | - | $5.90 B(+1.6%) |
| Mar 2021 | - | $5.81 B(-0.7%) |
| Dec 2020 | $5.85 B(+24.7%) | $5.85 B(-5.0%) |
| Sept 2020 | - | $6.16 B(+16.1%) |
| June 2020 | - | $5.30 B(+12.3%) |
| Mar 2020 | - | $4.72 B(+0.7%) |
| Dec 2019 | $4.69 B(+5.9%) | $4.69 B(+2.9%) |
| Sept 2019 | - | $4.56 B(+3.7%) |
| June 2019 | - | $4.39 B(-0.9%) |
| Mar 2019 | - | $4.44 B(+0.2%) |
| Dec 2018 | $4.43 B(-4.4%) | $4.43 B(-5.7%) |
| Sept 2018 | - | $4.70 B(+1.5%) |
| June 2018 | - | $4.62 B(+0.6%) |
| Mar 2018 | - | $4.60 B(-0.8%) |
| Dec 2017 | $4.63 B(+15.1%) | $4.63 B(+1.1%) |
| Sept 2017 | - | $4.58 B(+13.9%) |
| June 2017 | - | $4.02 B(+2.1%) |
| Mar 2017 | - | $3.94 B(-2.1%) |
| Dec 2016 | $4.02 B(+7.9%) | $4.02 B(+4.7%) |
| Sept 2016 | - | $3.84 B(+24.5%) |
| June 2016 | - | $3.09 B(-15.8%) |
| Mar 2016 | - | $3.67 B(-1.7%) |
| Dec 2015 | $3.73 B(+50.7%) | $3.73 B(+2.9%) |
| Sept 2015 | - | $3.62 B(-0.7%) |
| June 2015 | - | $3.65 B(-0.3%) |
| Mar 2015 | - | $3.66 B(+47.8%) |
| Dec 2014 | $2.48 B(+10.3%) | $2.48 B(+1.4%) |
| Sept 2014 | - | $2.44 B(+4.0%) |
| June 2014 | - | $2.35 B(+0.2%) |
| Mar 2014 | - | $2.34 B(+4.3%) |
| Dec 2013 | $2.24 B(+43.1%) | $2.24 B(+38.5%) |
| Sept 2013 | - | $1.62 B(+1.2%) |
| June 2013 | - | $1.60 B(+0.2%) |
| Mar 2013 | - | $1.60 B(+1.9%) |
| Dec 2012 | $1.57 B(+20.1%) | $1.57 B(+0.1%) |
| Sept 2012 | - | $1.57 B(+2.3%) |
| June 2012 | - | $1.53 B(+18.2%) |
| Mar 2012 | - | $1.30 B(-0.7%) |
| Dec 2011 | $1.31 B | $1.31 B(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $1.30 B(+1.1%) |
| June 2011 | - | $1.28 B(+1.3%) |
| Mar 2011 | - | $1.26 B(+0.1%) |
| Dec 2010 | $1.26 B(+37.7%) | $1.26 B(+1.5%) |
| Sept 2010 | - | $1.24 B(+26.3%) |
| June 2010 | - | $985.52 M(+2.0%) |
| Mar 2010 | - | $966.21 M(+5.3%) |
| Dec 2009 | $917.16 M(+1.2%) | $917.16 M(+5.5%) |
| Sept 2009 | - | $869.36 M(+3.0%) |
| June 2009 | - | $844.44 M(-6.2%) |
| Mar 2009 | - | $900.28 M(-0.7%) |
| Dec 2008 | $906.70 M(+11.2%) | $906.70 M(+5.5%) |
| Sept 2008 | - | $859.04 M(+0.5%) |
| June 2008 | - | $854.55 M(+3.2%) |
| Mar 2008 | - | $827.70 M(+1.5%) |
| Dec 2007 | $815.28 M(+75.9%) | $815.28 M(+3.1%) |
| Sept 2007 | - | $791.06 M(+1.2%) |
| June 2007 | - | $781.64 M(+73.8%) |
| Mar 2007 | - | $449.76 M(-3.0%) |
| Dec 2006 | $463.44 M(+137.3%) | $463.44 M(-0.8%) |
| Sept 2006 | - | $467.07 M(-0.4%) |
| June 2006 | - | $468.71 M(-4.0%) |
| Mar 2006 | - | $488.23 M(+150.0%) |
| Dec 2005 | $195.30 M(-16.2%) | $195.30 M(-6.5%) |
| Sept 2005 | - | $208.84 M(+24.9%) |
| June 2005 | - | $167.25 M(-7.6%) |
| Mar 2005 | - | $180.93 M(-22.3%) |
| Dec 2004 | $232.97 M(-9.1%) | $232.97 M(-25.4%) |
| Sept 2004 | - | $312.23 M(-10.1%) |
| June 2004 | - | $347.42 M(+45.2%) |
| Mar 2004 | - | $239.30 M(-6.6%) |
| Dec 2003 | $256.34 M(+131.7%) | $256.34 M(-9.9%) |
| Sept 2003 | - | $284.45 M(-7.2%) |
| June 2003 | - | $306.38 M(+67.3%) |
| Mar 2003 | - | $183.12 M(+65.5%) |
| Dec 2002 | $110.62 M(-35.6%) | $110.62 M(-13.2%) |
| Sept 2002 | - | $127.47 M(-10.2%) |
| June 2002 | - | $141.97 M(-9.7%) |
| Mar 2002 | - | $157.31 M(-8.4%) |
| Dec 2001 | $171.81 M(+123.3%) | $171.81 M(+90.1%) |
| Sept 2001 | - | $90.40 M(-8.1%) |
| June 2001 | - | $98.32 M(+50.2%) |
| Mar 2001 | - | $65.44 M(-14.9%) |
| Dec 2000 | $76.93 M(-25.7%) | $76.93 M(-7.7%) |
| Sept 2000 | - | $83.32 M(-3.2%) |
| June 2000 | - | $86.09 M(-8.9%) |
| Mar 2000 | - | $94.49 M(-8.7%) |
| Dec 1999 | $103.55 M(+228.6%) | $103.55 M(-8.0%) |
| Sept 1999 | - | $112.50 M(+118.9%) |
| June 1999 | - | $51.40 M(+91.8%) |
| Mar 1999 | - | $26.80 M |
| Dec 1998 | $31.51 M | - |
FAQ
- What is BioMarin Pharmaceutical annual total assets?
- What is the all time high annual total assets for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual total assets year-on-year change?
- What is BioMarin Pharmaceutical quarterly total assets?
- What is the all time high quarterly total assets for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly total assets year-on-year change?
What is BioMarin Pharmaceutical annual total assets?
The current annual total assets of BMRN is $6.84 B
What is the all time high annual total assets for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual total assets is $6.84 B
What is BioMarin Pharmaceutical annual total assets year-on-year change?
Over the past year, BMRN annual total assets has changed by +$466.53 M (+7.32%)
What is BioMarin Pharmaceutical quarterly total assets?
The current quarterly total assets of BMRN is $6.85 B
What is the all time high quarterly total assets for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly total assets is $7.07 B
What is BioMarin Pharmaceutical quarterly total assets year-on-year change?
Over the past year, BMRN quarterly total assets has changed by +$93.03 M (+1.38%)